arecoline has been researched along with morphine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulouard, M; Bureau, R; Butt-Gueulle, S; Dauphin, F; Daveu, C; Duchatelle, P; Dumuis, A; Lelong-Boulouard, V; Lemaître, S; Lepailleur, A; Lezoualc'h, F; Pfeiffer, B; Rault, S | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Pert, A | 1 |
| Fibiger, HC; Mason, ST; Roberts, DC | 1 |
| Maxey, G; Pert, A | 1 |
| Ariyanayagam, AD; Handley, SL | 1 |
| Contreras, E; Quijada, L; Tamayo, L | 1 |
| Gala, RR; Haisenleder, DJ | 1 |
| György, L; Phan, DV | 1 |
| Garau, L; Mulas, ML; Pepeu, G | 1 |
| Andreas, K; Nehring, K; Scherber, A | 1 |
| Scotto di Tella, AM | 1 |
| Czuczwar, SJ; Kleinrok, Z; Turski, L; Turski, W | 1 |
| Buccafusco, JJ; Gattu, M; Jonnala, RR; Shuster, LC; Zhang, LC | 1 |
| Bain, JN; Buccafusco, JJ | 1 |
| García-Algar, O; Marchei, E; Murillo, J; Pacifici, R; Pellegrini, M; Pichini, S; Puig, C; Vall, O | 1 |
| Alameda, F; García-Algar, O; Pacifici, R; Pellegrini, M; Pichini, S; Puig, C; Vall, O | 1 |
| García-Algar, O; Marchei, E; Murillo, J; Pacifici, R; Pellegrini, M; Pichini, S; Puig, C; Vall, O; Zuccaro, P | 1 |
18 other study(ies) available for arecoline and morphine
| Article | Year |
|---|---|
Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.
Topics: Animals; Chlorocebus aethiops; COS Cells; Humans; Indoles; Models, Molecular; Molecular Structure; Pyrazines; Radioligand Assay; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sulfonamides | 2009 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The cholinergic system and nociception in the primate: interactions with morphine.
Topics: Analgesia; Animals; Arecoline; Cholinesterase Inhibitors; Drug Synergism; Electroshock; Ganglionic Blockers; Ganglionic Stimulants; Haplorhini; Macaca mulatta; Morphine; Pain; Parasympathetic Nervous System; Parasympatholytics; Parasympathomimetics; Physostigmine; Scopolamine; Sensory Receptor Cells | 1975 |
Noradrenergic influences on catalepsy.
Topics: Animals; Animals, Newborn; Arecoline; Catalepsy; Haloperidol; Humans; Hydroxydopamines; Male; Morphine; Norepinephrine; Pilocarpine; Rats; Time Factors | 1978 |
Asymmetrical cross-tolerance between morphine and scopolamine induced antinociception in the primate: differential sites of action.
Topics: Analgesia; Animals; Arecoline; Brain; Drug Synergism; Drug Tolerance; Electroshock; Haplorhini; Macaca mulatta; Morphine; Pain; Receptors, Cholinergic; Scopolamine; Sensory Receptor Cells | 1975 |
Effect of sensory stimulation on the potency of cataleptogens.
Topics: Acoustic Stimulation; Animals; Arecoline; Catalepsy; Female; Haloperidol; Humans; Mice; Mice, Inbred Strains; Morphine; Photic Stimulation; Physical Stimulation; Pressure; Tail | 1975 |
Sensitivity changes to morphine and other drugs induced by cholinergic blockade.
Topics: Amphetamine; Analgesics; Animals; Arecoline; Atropine; Drug Tolerance; Female; Hexobarbital; Humans; Mice; Morphine; Parasympatholytics; Pentylenetetrazole; Reserpine; Sleep; Substance Withdrawal Syndrome; Time Factors | 1975 |
Restraint stress decreases afternoon plasma prolactin levels in female rats. Influence of neural antagonists and agonists on restraint-induced changes in plasma prolactin and corticosterone.
Topics: Animals; Arecoline; Atropine; Bicuculline; Corticosterone; Female; Injections, Intravenous; Morphine; Naloxone; Ovariectomy; Parasympathomimetics; Phenoxybenzamine; Phentolamine; Pimozide; Prolactin; Propranolol; Rats; Rats, Inbred Strains; Restraint, Physical; Stress, Physiological; Sympathomimetics | 1986 |
The pressor effect of oxotremorine and arecoline in rats.
Topics: Adrenalectomy; Adrenergic alpha-Antagonists; Animals; Arecoline; Atropine; Blood Pressure; Cerebral Ventricles; Cordotomy; Female; Ganglionic Blockers; Hexamethonium Compounds; Male; Mecamylamine; Morphine; Oxotremorine; Phenoxybenzamine; Phentolamine; Rats; Reserpine; Vagotomy | 1973 |
Does 5-hydroxytryptamine influence cholinergic mechanisms in the central nervous system?
Topics: Acetylcholine; Amphetamine; Analgesia; Animals; Arecoline; Brain; Cerebral Cortex; Electrocoagulation; Fenclonine; Mesencephalon; Morphine; Nerve Endings; Parasympathetic Nervous System; Pilocarpine; Rats; Serotonin; Time Factors | 1974 |
[Modification of the antinocifensive effect of arecoline by noradrenaline and serotonin].
Topics: Animals; Arecoline; Central Nervous System; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Electric Stimulation; Male; Mice; Morphine; Motor Neurons; Norepinephrine; Reserpine; Serotonin | 1974 |
[Modification, by lithium, of catalepsy induced by central cholinergic stimulants and morphine-like drugs].
Topics: Animals; Arecoline; Catalepsy; Chlorides; Dextromoramide; Female; Humans; Lithium; Lithium Chloride; Meperidine; Morphine; Oxotremorine; Rats; Rats, Inbred Strains; Sodium Chloride | 1981 |
Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy.
Topics: Animals; Arecoline; Catalepsy; Corpus Striatum; Drug Interactions; Haloperidol; Humans; Injections; Kainic Acid; Male; Morphine; Pilocarpine; Pyrrolidines; Rats; Rats, Inbred Strains | 1982 |
Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
Topics: Acetylcholinesterase; Animals; Arecoline; Blood Pressure; Brain; Cardiovascular System; Cholinergic Fibers; Cholinesterase Inhibitors; Drug Administration Schedule; Echothiophate Iodide; Heart Rate; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2000 |
A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
Topics: Analgesics, Opioid; Animals; Arecoline; Dose-Response Relationship, Drug; Infusions, Intravenous; Male; Morphine; Morphine Dependence; Muscarinic Agonists; Muscarinic Antagonists; Rats; Rats, Wistar; Recurrence; Reinforcement Schedule; Scopolamine; Self Administration; Substance Withdrawal Syndrome | 2007 |
Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry.
Topics: Adult; Arecoline; Calibration; Chromatography, High Pressure Liquid; Female; Fetal Blood; Humans; Infant, Newborn; Meconium; Pregnancy; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2003 |
Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes.
Topics: Areca; Arecoline; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meconium; Neonatal Abstinence Syndrome; Placenta; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects | 2005 |
Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
Topics: Abortion, Induced; Adult; Arecoline; Body Height; Cholinergic Agonists; Cocaine; Dopamine Uptake Inhibitors; Female; Forensic Medicine; Gravidity; Hallucinogens; Humans; Infant, Low Birth Weight; Infant, Newborn; Italy; Marijuana Smoking; Maternal-Fetal Exchange; Meconium; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Pregnancy; Smoking; Spain; Substance Abuse Detection; Substance-Related Disorders | 2005 |